New drug duo takes on aggressive lung cancer in first-line trial

NCT ID NCT07155174

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 32 times

Summary

This study tests a new drug, ABBV-706, combined with atezolizumab against standard treatment for people with extensive-stage small cell lung cancer that hasn't been treated yet. About 180 adults will receive either the new combination or standard care to find the best dose and see if it works better. The goal is to control the cancer and improve survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AZ Maria Middelares /ID# 277027
RECRUITING

Ghent, Oost-Vlaanderen, 9000, Belgium
Assuta Ashdod Medical Center /ID# 276661
RECRUITING

Ashdod, Southern District, 7747600, Israel
Chung Shan Medical University Hospital /ID# 277660
RECRUITING

Taichung, 402, Taiwan
Chungbuk National University Hospital /ID# 277429
RECRUITING

Cheongju-si, North Chungcheong, 28644, South Korea
Complejo Hospitalario Universitario A Coruña /ID# 276922
RECRUITING

A Coruña, A Coruna, 15006, Spain
Fort Wayne Medical Oncology And Hematology /ID# 277336
RECRUITING

Fort Wayne, Indiana, 46804, United States
Groupe Sante CHC - Clinique du MontLegia /ID# 276783
RECRUITING

Liège, Liege, 4000, Belgium
Hadassah Medical Center-Hebrew University /ID# 276662
RECRUITING

Jerusalem, 91120, Israel
Hospital Regional Universitario de Malaga /ID# 276927
RECRUITING

Málaga, Andalusia, 29010, Spain
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 277267
RECRUITING

Kaohsiung City, 807, Taiwan
Linkou Chang Gung Memorial Hospital /ID# 277264
RECRUITING

Taoyuan City, 333, Taiwan
Lungenfachklinik Immenhausen /ID# 278005
RECRUITING

Immenhausen, Hesse, 34376, Germany

Contact Phone: •••-•••-••••
Meir Medical Center /ID# 277292
RECRUITING

Kfar Saba, Central District, 4428164, Israel
Moffitt Cancer Center /ID# 277573
RECRUITING

Tampa, Florida, 33612, United States
National Cancer Center /ID# 277434
RECRUITING

Goyang-si, Gyeonggido, 10408, South Korea
National Cancer Center Hospital /ID# 277237
RECRUITING

Chuo-Ku, Tokyo, 104-0045, Japan
National Cancer Center Hospital East /ID# 277239
RECRUITING

Kashiwa-shi, Chiba, 277-8577, Japan
Ocala Oncology Center /ID# 278269
RECRUITING

Ocala, Florida, 34474, United States
Rambam Health Care Campus- Haifa /ID# 276663
RECRUITING

Haifa, 3525408, Israel
Shizuoka Cancer Center /ID# 277243
RECRUITING

Sunto-gun, Shizuoka, 411-8777, Japan
Taipei Veterans General Hospital /ID# 277263
RECRUITING

Taipei, 112, Taiwan
The Chaim Sheba Medical Center /ID# 276660
RECRUITING

Ramat Gan, Tel Aviv, 5265601, Israel
The University of Texas MD Anderson Cancer Center /ID# 277929
RECRUITING

Houston, Texas, 77030, United States
Tokyo Metropolitan Komagome Hospital /ID# 277335
RECRUITING

Bunkyo Ku, Tokyo, 113-8677, Japan
University Hospitals Cleveland Medical Center /ID# 277556
RECRUITING

Cleveland, Ohio, 44106, United States
Virginia Cancer Specialists - Fairfax /ID# 278298
RECRUITING

Fairfax, Virginia, 22031, United States
Wakayama Medical University Hospital /ID# 277260
RECRUITING

Wakayama, Wakayama, 641-8510, Japan
Yale University School of Medicine /ID# 278181
RECRUITING

New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.

SMALL CELL LUNG CANCER